Clinical Trials in Salt Lake City

Showing 5661-5680 of 12,670 trials

Psychological Distress and Outcomes in Hip Preservation Patients

NCT01550263

This is an investigatory study to determine whether high levels of pre-operative psychological distress predict worse outcomes after hip preservation. This is a low risk study and does not alter the treatment or course of care for patients undergoing this procedure

Psychological Distress

University of Utah217 participantsStarted Jan 2012

Salt Lake City, Utah, United States

COMPLETEDPhase 2< 1 mile

Sargramostim Use in COVID-19 to Recover Patient Health

NCT04707664

The purpose of this research is to understand if the study drug, also called sargramostim or Leukine®, can help prevent the worsening of COVID-19 when the study drug is inhaled. This study will also help researchers understand if inhaled sargramostim can help prevent visits to the emergency room or hospitalization, or death.

Covid19SARS-CoV Infection

Partner Therapeutics, Inc.600 participantsStarted Apr 2021

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Canoga Park, California, United States +34 more locations

Psychological Distress and Outcomes in Hip Preservation Patients

Sargramostim Use in COVID-19 to Recover Patient Health

Find Trials by Condition in Salt Lake City

Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

User Performance of the TV4 BGMS

A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer

PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement

Characterization & Treatment of Chronic Pain After Moderate to Severe TBI

Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants

A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors

Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC

A Study Assessing AR-13503 Implant in Subjects With nAMD or DME

A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis

Validation of a Salivary miRNA Diagnostic Test for ASD

A Study of Modified Stem Cells in Stable Ischemic Stroke

Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) Study

Improving Quality by Maintaining Accurate Problems in the EHR

Pembrolizumab Plus Y90 Radioembolization in HCC Subjects